Charles Gauthier

Charles Gauthier has a strong background in program and project management in the pharmaceutical industry. Charles held the role of Senior Director of Portfolio and Program Management at Cerevel Therapeutics, where they led the development of the lead candidate in Parkinson's Disease and handled program strategy, integrated development planning, and decision-making. Prior to that, they served as Senior Director of Program Management at ImmunoGen, Inc., overseeing the pivotal program for mirvetuximab soravtansine and collaborating with Merck on a combination study. Gauthier also gained extensive experience at Novartis Institutes for BioMedical Research (NIBR), where they held various positions, including Associate Director of Project Manager, Manager of Research Project Management, and Portfolio Manager. Charles'sresponsibilities at NIBR encompassed project management, alliance management, and portfolio coordination. Gauthier started their career as a Senior Research Associate at Millennium Pharmaceuticals and worked as a Lab Chemist at Safety Kleen.

Charles Gauthier's education history includes earning an MBA degree in Business Administration and Management, General from Suffolk University - Sawyer Business School from 2004 to 2008. In 2004, they also obtained a Certificate in Project Management from Boston University. Charles pursued Database Management at Northeastern University from 2001 to 2003, although no specific degree is mentioned. Charles Gauthier completed their undergraduate studies at Worcester State University, graduating with a Bachelor of Science (BS) degree in Biology from 1996 to 2000.